about
Role of biologics in severe eosinophilic asthma - focus on reslizumabEosinophilic esophagitis: published evidences for disease subtypes, indications for patient subpopulations, and how to translate patient observations to murine experimental modelsClinical profile of patients with adult-onset eosinophilic asthmaMetabolomics analysis identifies different metabotypes of asthma severity.Self-reported racial/ethnic discrimination and bronchodilator response in African American youth with asthmaAltered expression of regulatory T and Th17 cells in murine bronchial asthmaHumoral immune factors and asthma among American Indian children: a case-control study.A randomized trial of the efficacy and safety of quilizumab in adults with inadequately controlled allergic asthma.Subepithelial Accumulation of Versican in a Cockroach Antigen-Induced Murine Model of Allergic Asthma.Current concepts of severe asthmaTreatment of moderate to severe pediatric asthma: Omalizumab and potential future use of monoclonal antibodies.The Healthy Infant Nasal Transcriptome: A Benchmark StudyA novel microbe-based treatment that attenuates the inflammatory profile in a mouse model of allergic airway diseaseAsthma-COPD overlap syndrome in the US: a prospective population-based analysis of patient-reported outcomes and health care utilization.Clinical and biological characteristics of the French COBRA cohort of adult subjects with asthma.Parasites and asthma.Can biomarkers help us hit targets in difficult-to-treat asthma?IRF5 distinguishes severe asthma in humans and drives Th1 phenotype and airway hyperreactivity in miceEmerging Roles of Apolipoprotein E and Apolipoprotein A-I in the Pathogenesis and Treatment of Lung Disease.The nasal mucosal late allergic reaction to grass pollen involves type 2 inflammation (IL-5 and IL-13), the inflammasome (IL-1β), and complement.Vitamin E and the risk of childhood asthma.Improving the diagnosis of eosinophilic asthma.The A's Have It: Developing Apolipoprotein A-I Mimetic Peptides Into a Novel Treatment for Asthma.Store-operated calcium entry is required for sustained contraction and Ca2+ oscillations of airway smooth muscle.Genetic variants and risk of asthma in an American Indian population.Asthma as a disruption in iron homeostasis.Diet and asthma: need to account for asthma type and level of prevention.Severe asthma in humans and mouse model suggests a CXCL10 signature underlies corticosteroid-resistant Th1 bias.Airway Progenitor Clone Formation Is Enhanced by Y-27632-Dependent Changes in the Transcriptome.Th1 Signatures Are Present in the Lower Airways of Children with Severe Asthma, Regardless of Allergic Status.Severe eosinophilic asthma: from the pathogenic role of interleukin-5 to the therapeutic action of mepolizumab.First-in-Human Study With the Inhaled TLR9 Oligonucleotide Agonist AZD1419 Results in Interferon Responses in the Lung, and Is Safe and Well-Tolerated.T cell types that take your breath away.Strain Differences in a Murine Model of Air Pollutant-induced Nonatopic Asthma and Rhinitis.Predictive Biomarkers for Asthma Therapy.Eosinophil persistence in vivo and sustained viability ex vivo in response to respiratory challenge with fungal allergens.Dupilumab for the treatment of asthma.Neurotrophins in Asthma.Personalized medicine with biologics for severe type 2 asthma: current status and future prospects.Can Controlling Endoplasmic Reticulum Dysfunction Treat Allergic Inflammation in Severe Asthma With Fungal Sensitization?
P2860
Q26738503-E4D79A2B-3308-416E-A884-601BABC1C42CQ26741559-C59710C0-968A-4F2D-9C05-D7AE216ADA4CQ28596640-0CBE0079-72F6-4980-BC05-DFC8EF683367Q33587291-FFA97BF2-9715-4D9D-A327-F374DBDF0AF3Q33793034-1AAA1AD6-3049-446E-B7D4-1D565086ECD8Q33847426-000BB2AB-1F41-48DA-B713-1C14B4BBC8B2Q36050653-DEB5F90E-1066-4106-82D6-CD614B0C38C0Q36700648-38F17AC3-5C0A-4197-A874-97296518A269Q36954958-E2CA35D2-84CF-4235-8551-87CB08D41CE4Q37042266-2F200733-8CEA-41F4-BC7C-E5136C7A790AQ37062124-699B9BCB-21E8-4BCC-AB3E-B268592061CAQ37277996-5B909AE9-36EF-4C50-BD1D-097A5D8EB9E2Q37335659-05697FAD-0D4B-4AD8-82E0-E09F1DF24C2CQ37638731-CA2D347A-CA65-4174-B545-D798F9B687ABQ38609480-F3294CBF-2217-4A99-BD69-58C27D07FF44Q38660878-A38CE89D-D881-479D-A1B5-2CF99703DE4EQ38752058-E3EEDD8A-67CD-4558-A40D-AF2B7B6A1DD1Q38780046-8E5526C9-1AEF-484A-A0A1-E0B2347C8D95Q38807248-D16A1FB2-FFE7-4F71-8E19-C82A21827C8FQ38817069-830E12C0-8895-4CC4-9360-F0878376748EQ38819794-9A72598F-F45B-420E-9D7C-A920015F9EC2Q38821540-46063B37-D2FF-4217-BAAA-E2053A3D4F8EQ38871923-5BB68766-B4BA-4701-A1A3-64076D19A564Q39616952-A830561B-292E-40AB-A67F-EC00AC4C71EEQ40138527-ECABA724-B62C-47DA-8D0A-848F93A3B13FQ40551737-EFC3E459-D85A-497F-8E9D-75D8F1AD0689Q40554702-AD2D9CB9-C4BC-422E-A08A-858EC253FBF6Q40952721-1D8CF560-FCBD-4527-8A9B-81B910EC04E8Q41091063-900A7580-9037-4E06-B199-E4720480329CQ41931927-4459078A-AA40-41D8-A68B-D64D0081D471Q45676532-AD050701-4E60-42C9-80C4-6CEB4B537CD9Q46090169-AF3F5DD2-8676-4CDA-B962-86932F111027Q46130011-FD1DE550-03C6-4308-BB19-DE28817AC221Q46435043-6C57D5F0-919D-42B1-9037-FEE5C2288B68Q47683405-C865E50D-F7AB-453F-99F6-682F49F12B4FQ47732959-4B985159-6F4C-4759-90B4-E960811FAF46Q49486790-30B780D7-6305-43AC-9747-65D9856A6DEBQ49909129-B2B21D88-BCA3-4F9E-BBF7-1D33E99855BCQ50073556-2E236BDE-4980-4F5A-8F1A-86497B1299B8Q50144888-F6E136D7-CC37-4596-8D88-06D77C84B9E5
P2860
description
2015 nî lūn-bûn
@nan
2015 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Evolving Concepts of Asthma.
@ast
Evolving Concepts of Asthma.
@en
type
label
Evolving Concepts of Asthma.
@ast
Evolving Concepts of Asthma.
@en
prefLabel
Evolving Concepts of Asthma.
@ast
Evolving Concepts of Asthma.
@en
P2860
P1476
Evolving Concepts of Asthma.
@en
P2093
Anuradha Ray
Sally E Wenzel
P2860
P304
P356
10.1164/RCCM.201504-0763PP
P407
P577
2015-07-10T00:00:00Z